# Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects

> **NCT01295320** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 129 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **PROCEDURE:** Blood sample

## Key facts

- **NCT ID:** NCT01295320
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-28
- **Primary completion:** 2013-06-20
- **Final completion:** 2013-06-20
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2017-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01295320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01295320, "Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01295320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*